132 GENES FOUND
Show / hide columns »
XML |
RDF |
TAB |
« prev | Page next »
KCNH8 Potassium channel, voltage gated eag related subfamily H, member 8 Predicted membrane proteins Tissue enhanced
KCNJ1 Potassium channel, inwardly rectifying subfamily J, member 1 Disease related genes Tissue enriched
KCNJ10 Potassium channel, inwardly rectifying subfamily J, member 10 Disease related genes Group enriched
KCNJ11 Potassium channel, inwardly rectifying subfamily J, member 11 Disease related genes Tissue enhanced
KCNJ12 Potassium channel, inwardly rectifying subfamily J, member 12 FDA approved drug targets Nucleoplasm Group enriched
KCNJ13 Potassium channel, inwardly rectifying subfamily J, member 13 Disease related genes Group enriched
KCNJ14 Potassium channel, inwardly rectifying subfamily J, member 14 Predicted membrane proteins Nucleoli Mixed
KCNJ15 Potassium channel, inwardly rectifying subfamily J, member 15 Predicted intracellular proteins Vesicles Tissue enhanced
KCNJ16 Potassium channel, inwardly rectifying subfamily J, member 16 Predicted intracellular proteins Vesicles Group enriched
KCNJ2 Potassium channel, inwardly rectifying subfamily J, member 2 Disease related genes Tissue enhanced
KCNJ3 Potassium channel, inwardly rectifying subfamily J, member 3 Plasma proteins Tissue enhanced
KCNJ4 Potassium channel, inwardly rectifying subfamily J, member 4 Predicted membrane proteins Group enriched
KCNJ5 Potassium channel, inwardly rectifying subfamily J, member 5 Cancer-related genes Tissue enhanced
KCNJ6 Potassium channel, inwardly rectifying subfamily J, member 6 Disease related genes Tissue enriched
KCNJ8 Potassium channel, inwardly rectifying subfamily J, member 8 Disease related genes Mixed
KCNJ9 Potassium channel, inwardly rectifying subfamily J, member 9 Predicted membrane proteins Tissue enriched
KCNK1 Potassium channel, two pore domain subfamily K, member 1 Predicted membrane proteins Vesicles Mixed
KCNK12 Potassium channel, two pore domain subfamily K, member 12 Predicted membrane proteins Tissue enriched
KCNK13 Potassium channel, two pore domain subfamily K, member 13 Predicted membrane proteins Nuclear speckles Tissue enhanced
KCNK15 Potassium channel, two pore domain subfamily K, member 15 Predicted membrane proteins Tissue enhanced
KCNK16 Potassium channel, two pore domain subfamily K, member 16 Predicted membrane proteins Tissue enhanced
KCNK17 Potassium channel, two pore domain subfamily K, member 17 Predicted membrane proteins Tissue enhanced
KCNK18 Potassium channel, two pore domain subfamily K, member 18 Disease related genes Not detected
KCNK2 Potassium channel, two pore domain subfamily K, member 2 FDA approved drug targets Mitochondria Tissue enhanced
KCNK3 Potassium channel, two pore domain subfamily K, member 3 Disease related genes Tissue enhanced
KCNK4 Potassium channel, two pore domain subfamily K, member 4 Predicted intracellular proteins Tissue enriched
KCNK5 Potassium channel, two pore domain subfamily K, member 5 Predicted membrane proteins Nucleus Tissue enhanced
KCNK6 Potassium channel, two pore domain subfamily K, member 6 Predicted membrane proteins Plasma membrane Mixed
KCNK7 Potassium channel, two pore domain subfamily K, member 7 Predicted intracellular proteins Plasma membrane Tissue enriched
KCNK9 Potassium channel, two pore domain subfamily K, member 9 Disease related genes Group enriched
KCNMA1 Potassium channel, calcium activated large conductance subfamily M alpha, member 1 Disease related genes Tissue enhanced
KCNN1 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1 Predicted intracellular proteins Actin filaments Tissue enriched
KCNN2 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2 Plasma proteins Nucleoplasm Tissue enhanced
KCNN3 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3 Predicted membrane proteins Nucleoplasm Tissue enhanced
KCNN4 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 Disease related genes Tissue enhanced
KCNQ1 Potassium channel, voltage gated KQT-like subfamily Q, member 1 Disease related genes Tissue enhanced
KCNQ2 Potassium channel, voltage gated KQT-like subfamily Q, member 2 Disease related genes Endoplasmic reticulum Tissue enriched
KCNQ3 Potassium channel, voltage gated KQT-like subfamily Q, member 3 Disease related genes Tissue enriched
KCNQ4 Potassium channel, voltage gated KQT-like subfamily Q, member 4 Disease related genes Mixed
KCNQ5 Potassium channel, voltage gated KQT-like subfamily Q, member 5 Predicted intracellular proteins Vesicles Tissue enhanced
KCNS1 Potassium voltage-gated channel, modifier subfamily S, member 1 Predicted membrane proteins Tissue enhanced
KCNS2 Potassium voltage-gated channel, modifier subfamily S, member 2 Predicted membrane proteins Tissue enhanced
KCNS3 Potassium voltage-gated channel, modifier subfamily S, member 3 Predicted intracellular proteins Golgi apparatus Tissue enhanced
KCNT1 Potassium channel, sodium activated subfamily T, member 1 Disease related genes Group enriched
KCNT2 Potassium channel, sodium activated subfamily T, member 2 Predicted intracellular proteins Vesicles Tissue enhanced
KCNV1 Potassium channel, voltage gated modifier subfamily V, member 1 Predicted membrane proteins Tissue enriched
KCNV2 Potassium channel, voltage gated modifier subfamily V, member 2 Disease related genes Tissue enriched
MCOLN1 Mucolipin 1 Disease related genes Plasma membrane Expressed in all
MCOLN2 Mucolipin 2 Predicted membrane proteins Intermediate filaments Mixed
MCOLN3 Mucolipin 3 Predicted membrane proteins Nucleoli Tissue enhanced
« prev | Page next »
